miR-210
(Plasmid
#31642)
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 31642 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCDH-CMV-MCS-EF1
-
Backbone manufacturerSystem Biosciences
- Backbone size w/o insert (bp) 7545
-
Vector typeMammalian Expression, Lentiviral ; miRNA expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Stbl3
-
Growth instructionsStbl3
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemiR-210
-
Alt namemicroRNA-210
-
SpeciesH. sapiens (human)
-
Entrez GeneMIR210 (a.k.a. MIRN210, mir-210)
-
Tag
/ Fusion Protein
- GFP (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer CMV-Fwd (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
miR-210 was a gift from Joseph Wu (Addgene plasmid # 31642) -
For your References section:
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC. Circulation. 2010 Sep 14. 122(11 Suppl):S124-31. 10.1161/CIRCULATIONAHA.109.928424 PubMed 20837903